Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
A technical investigation has identified that certain lots of oxoid columbia blood agar base cm0331 may not provide acceptable microbiological performance when used in selective formulations targeting staphylococcus and streptococcus spp. however these formulations continue to perform correctly with the qc strains detailed in the qc specs. performance with some clinical strains may be atypical.